5 August 2019 - Deborah Wilkes
Archived
RB said it had "focused and detailed action plans in place" to accelerate growth at its Health division, as sales fell by 1% on a like-for-like basis in the second quarter of 2019.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.